Our Services

Technology Assessment and Due Diligence

Thorough evaluation of bioinformatics technologies and analytical methodology, we scrutinize the scientific rationality, likelihood of validation, and market potential to facilitate informed investment decisions by investment firms.
Click to learn more.

Risk Mitigation Strategies

Implementing rigorous risk mitigation strategies, ensuring the rigorous assessment of data quality, reproducibility, and correct interpretation. By incorporating these steps, we help enhance the reliability and credibility of the bioinformatics analyses under consideration.
Click to learn more.

Our Resources

Technology Focus:
Driving healthcare innovation, we specialize in assessing novel clinical tools using cutting-edge biomarkers, gene expression, immunotherapy, genotyping, and sequencing methodologies, including whole genome, whole exome, targeted sequencing, and single-cell sequencing.

Collaborative Network:
HelixHarbor maintains a collaborative network of bioinformatics specialists, clinical experts, and patent attorneys, ensuring a comprehensive evaluation of informatics solutions that encompasses scientific, clinical, and legal considerations.

Client-Centric Approach:
HelixHarbor is dedicated to a client-centric approach, tailoring informatics assessments to meet the specific needs and investment objectives of investment firms. The company aims to provide actionable intelligence and strategic guidance, facilitating successful and sustainable ventures in the ever-evolving landscape of biotechnology.

blue and black ball on blue and white checkered textile

two women sitting on leather chairs in front of table